Archive press releases 2017

GKC names John Schellhorn President and CEO - 5 October 2017

GKC announced today that it has appointed John Schellhorn as its new President and CEO. Schellhorn will also be joining the company’s Board of Directors.


Schellhorn joins GKC with a proven track record to spearhead the company's accelerated growth strategy to meet the demand for its lead product, the PKG™ system.

Please read the full press release here

Global Kinetics Corporation secures first US patent for its digital health system - 16 August 2017

GKC announced today it has received Notice of Allowance for a U.S. patent application, protecting the company's lead product, the PKG system.

The patent application pertains to the objective measurement of bradykinesia. Bradykinesia, or slowness of movement, is one of the most common symptoms, and a defining feature, of Parkinson's disease. The capacity to continuously measure this movement symptom underpins the PKG system.

The full press release can be accessed here

Evaluation of the Parkinson's Kinetigraph in monitoring and managing Parkinson's disease

While objective measurement is routine in clinical care of most conditions, this has not been the case for Parkinson's™ Disease. Recent innovations make objective measurement in Parkinson's™ Disease possible and its utility and how this should be assessed is discussed here.  Please read the full article here

GKC and Parkinson's Foundation announce first patient enrolled in APPRISE clinical study - 31 May 2017

APPRISE is multi-center, randomized, controlled clinical study which assess the use of the Parkinson’s KinetiGraph™ (PKG™) system – called the Personal KinetiGraph in the US - for identifying patients who require a change to their clinical management plan, and the platform’s ability to help improve patient outcomes.

Please read the full press release here

Big data highlights unmet needs & global variations in PD - 16 June 2017

Global Kinetics Corporation (GKC), today announced that it has developed a dataset of more than 10,000 reports of symptoms from patients with PD. The database was used to analyze symptomology from patients across the globe and presented in a poster at the recent International Congress of Parkinson’s Disease and Movement Disorders.

Please read the full press release here

GKC present data on its PKG at the 21st International Movement Disorder Congress - 23 May 2017

Global Kinetics Corporation (GKC), a leader in digital health technology for people with Parkinson’s disease, today announced that four abstracts have been accepted to the 21st International Congress of Parkinson’s Disease and Movement Disorders, occurring June 4-8 in Vancouver, British Columbia. The studies presented involve the company’s proprietary Parkinson’s KinetiGraph™ (PKG™) technology – called the Personal KinetiGraph™ in the US.

To read more about the study and the collaboration, click here

Globalk Kinetics Corporation joins quest to predict Parkinson's- 31st January 2017

Global Kinetics Corporation is pleased to be working with neurologist and Parkinson's UK-funded researcher. Dr Alastair Noyce from the Institute of Neurology, University College London, to help spot early warning signs of Parkinson's.

To read more about the study and the collaboration, click here

CE marked secured for second generation PKG system - 4 January 2017

Global Kinetics Corporation, leader in digital health technology for people with Parkinson’s has secured CE marking on its new second generation Parkinson’s KinetiGraph™ (PKG™) system, indicating that the product complies with European health and safety requirements and legislation.

Please read the full press release here